Keywords: عوامل ایمن سازی; Relapsed/refractory multiple myeloma; Treatment strategies; Immunomodulatory agents; IMiDs; Proteasome inhibitors; Outcomes; Health-related quality of life;
مقالات ISI عوامل ایمن سازی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عوامل ایمن سازی; Chronic lymphocytic leukemia; Elderly; Functional status; Geriatric assessment; Alkylators; Purine analogs; Anti-CD20 monoclonal antibodies; Immunomodulatory agents; Bruton's tyrosine kinase inhibitors; PI3 kinase inhibitors;
Keywords: عوامل ایمن سازی; Drug; Response To Therapy; Prognostic Factor; Biomarker; ACT; Active Ulcerative Colitis Trials; ASCA; anti-Saccharomyces cerevisiae antibodies; ASUC; acute severe ulcerative colitis; CI; confidence interval; CRP; C-reactive protein level; CS; corticostero
Keywords: عوامل ایمن سازی; sepsis; immunosuppression; co-inhibitory molecules; cytokines; immunomodulatory agents
Keywords: عوامل ایمن سازی; Immunomodulatory agents; Proteasome inhibitors; Maintenance therapy; Reduced-intensity conditioning;
Keywords: عوامل ایمن سازی; Influenza; Adjunctive therapies; Immunomodulatory agents;
Keywords: عوامل ایمن سازی; Myelodysplastic syndrome (MDS); Systematic review; Clinical trials; Immunomodulatory agents; Lenalidomide; Thalidomide;
Immunosuppressive mechanism of Hypoderma lineatum secreted serine esterase, a potential modulatory method used to inhibit transplant rejection
Keywords: عوامل ایمن سازی; Cytokines; ELISA; Graft rejection; Host immune system; Hypodermin A; Immunomodulatory agents; Immunosuppression; Immunosuppressive; Interferon; Interleukin; Transplantation;
The role of adjuvant immunomodulatory agents for treatment of severe influenza
Keywords: عوامل ایمن سازی; Influenza; Adjunctive therapies; Immunomodulatory agents;
Novel Drug Combinations for the Management of Relapsed/Refractory Multiple Myeloma
Keywords: عوامل ایمن سازی; Histone deacetylase inhibitors; Immunomodulatory agents; Monoclonal antibodies; Proteasome inhibitors; Treatment
Chronic Leukemia
Keywords: عوامل ایمن سازی; Chronic myeloid leukemia; Chronic lymphocytic leukemia; Leukocytosis; Lymphocytosis; Tyrosine kinase inhibitors; Alkylating agents; Monoclonal antibodies; Immunomodulatory agents;
Treating influenza with statins and other immunomodulatory agents
Keywords: عوامل ایمن سازی; Influenza; Statins; Immunomodulatory agents; Metabolic syndrome; Public health
Observations of Second Primary Malignancy in Patients With Multiple Myeloma
Keywords: عوامل ایمن سازی; Immunomodulatory agents; Lenalidomide; Second primary malignancy; Thalidomide
Phase II Trial of Syncopated Thalidomide, Lenalidomide, and Weekly Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Keywords: عوامل ایمن سازی; Immunomodulatory agents; Induction therapy; Myeloma
New treatment approaches for older adults with multiple myeloma
Keywords: عوامل ایمن سازی; Multiple myeloma; Geriatrics; Aging; Chemotherapy; Immunomodulatory agents; Proteosome inhibitors
Mechanism of Action of Glatiramer Acetate in Treatment of Multiple Sclerosis
Keywords: عوامل ایمن سازی; Multiple sclerosis; glatiramer acetate; immunomodulatory agents; mechanism of action; antigen presenting cells;
Statins-Treatment Option for Central Nervous System Autoimmune Disease?
Keywords: عوامل ایمن سازی; Multiple sclerosis; immunomodulatory agents; statins; experimental autoimmune encephalomyelitis; novel therapy;
Lenalidomide in multiple myeloma
Keywords: عوامل ایمن سازی; lenalidomide; myeloma; dexamethasone; immunomodulatory agents; thalidomide
Role of Panitumumab in the Management of Metastatic Colorectal Cancer
Keywords: عوامل ایمن سازی; Antibiotics; Cetuximab; Epidermal growth factor; Immunomodulatory agents; Rash; Steroids;